Inflection Biosciences is an early stage, drug development company which won Start-Up of the Year at the Pharma Industry Awards 2014. Due to the successful pre-clinical testing of treatments that it has licensed and hopes to bring to the market, the company has received upwards of €2.5m in venture capital to date.
Are you looking for someone or
something in particular?
Select how you would like to share using the options below